Review: Î²-blockers are less effective than other antihypertensive drugs for reducing risk for stroke in primary hypertension
- Betablocker senken MortalitÃ¤t nach Myokardinfarkt -- auch bei COPD-Patienten. Markun, Stefan // Praxis (16618157);4/9/2014, Vol. 103 Issue 8, p471
No abstract available.
- Beta-blockers: recognising the assets in relation to coronary artery disease. Kendall, M. J. // Basic Research in Cardiology;Nov2000 Supplement 1, Vol. 95, pI31
Beta-blockers have been shown to reduce the risk of coronary events and reduce the mortality of patients with hypertension and in those who have had a myocardial infarction. Furthermore, the evidence for long-term benefits in these two patient groups are much more convincing for beta-blockers...
- Sudden death: ACE inhibitors and beta-blockers. Landray, M. J. // Basic Research in Cardiology;Nov2000 Supplement 1, Vol. 95, pI37
Sudden death is extremely common in patients suffering from cardiovascular diseases. At least one third of those with hypertension and probably about half of those who survive a myocardial infarction or suffer from cardiac failure who die in a clinical trial, die suddenly. Beta-blockers reduce...
- atenolol. // Royal Society of Medicine: Medicines;2002, p91
This article presents information on beta-blocker atenolol. The drug can be used as an antihypertensive for raised blood pressure, as an anti-angina treatment to relieve symptoms and to improve exercise tolerance, to regularize heartbeat and after anti-arrhythmic myocardial infarction. Atenolol...
- Betim. // Royal Society of Medicine: Medicines;2002, p113
The article presents information on Betim, a proprietary, prescription-only preparation drug of the beta-blocker timolol maleate. This drug can used as an antihypertensive for high blood pressure, as an anti-angina treatment to relieve symptoms and improve exercise tolerance and to treat...
- The Beneficial Effect of the Beta Blocker Timolol In Stable Angina Pectoris. Di Segni, Elio; Fidelman, Eva; David, Daniel; Klein, Herman O.; Kaplinsky, Elieser // Angiology;Apr1980, Vol. 31 Issue 4, p238
Timolol is a new beta blocker with cardioselective properties. A single blind controlled study was performed to assess the efficacy of timolol maleate in doses of 10 to 30 mg per day in 20 patients affected by stable angina pectoris. The patients received a placebo for a baseline period of 2...
- Adding aspirin to beta blocker therapy lowers rate of first MIs. // Geriatrics;May1993, Vol. 48 Issue 5, p87
This article reports that adding aspirin at a dose of only 75 mg/d to the beta blocker sotalol for 2 years or more reduces the risk of a first myocardial infarction (MI) in older patients with chronic stable angina, according to the authors of a randomized, double-blind, multicenter from Sweden....
- Effect of beta blockers on mortality following MI. KIRCHNER, JEFFREY T. // American Family Physician;1/15/1999, Vol. 59 Issue 2, p444
Presents an abstract of the study `Effect of Beta-Blockade on Mortality Among High-Risk and Low-Risk Patients After Myocardial Infarction,' by S. S. Gottlieb, et al, from the `New England Journal of Medicine' dated August 1998.
- Post-MI: Low-dose beta blockers as good as, maybe better than, high. // Modern Medicine;Jun98, Vol. 66 Issue 6, p30
Presents an abstract of the article `Beta-Blocker Dosages and Mortality After Myocardial Infarction: Data from a Large Health Maintenance Organization,' by H.V. Barron, S. Viskin, et al from the `Archives of Internal Medicine.'